Merck KGaA

Equities

MRK

DE0006599905

Market Closed - Xetra Other stock markets 11:35:06 2026-04-17 am EDT			5-day change	1st Jan Change
118.50 ^EUR	+2.91%		+5.95%	-3.34%

Apr. 16	Merck KGaA Price Target, Forecasts Cut as AlphaValue/Baader Europe Notes 'Restrained' Growth Prospects	MT
Apr. 16	Merck: Pharma business’s reinvigoration remains key for re-rating

Transcript : Merck KGaA, Q4 2025 Earnings Call, Mar 05, 2026

Published on 03/05/2026 at 10:21 am EST - Modified on 03/05/2026 at 05:08 pm EST

S&P Capital IQ

Presentation Operator Message
Operator (Operator)

Dear ladies and gentlemen, welcome to the Merck Investor and Analyst Conference Call on Fourth Quarter and Full Year 2025. [Operator Instructions] I'm

This article is reserved for subscribers

Unlock the article : SUBSCRIBE!

Already a customer? Log In

Latest news about Merck KGaA

Apr. 16	Merck KGaA Price Target, Forecasts Cut as AlphaValue/Baader Europe Notes 'Restrained' Growth Prospects	MT
Apr. 16	Merck: Pharma business’s reinvigoration remains key for re-rating
Apr. 16	MERCK KGAA : Gets a Buy rating from Goldman Sachs	ZD
Apr. 16	Goldman Sachs trims Merck KGaA price target to 147 euros - "Buy"	DP
Apr. 14	Pharma sector doubles down on AI amid hopes of slashing costs, timelines	RE
Apr. 08	AlphaValue/Baader Europe Lowers Target Price, Estimates for Sanofi Amid R&D Setbacks	MT
Apr. 01	Germany's DAX Index Surges; Merck KGaA Shares Up	MT
Apr. 01	Merck KGaA Completes Purchase of JSR Life Sciences' Chromatography Unit	MT
Apr. 01	Explainer: GmbH, NV, KGaA, Plc, SpA, Oyj, SGPS… what are we talking about?
Mar. 26	Substantial pay hikes for many DAX CEOs - Sewing climbs to second place	RE
Mar. 25	Pay rise for 585,000 workers in the chemical and pharmaceutical sectors	DP
Mar. 24	Collective bargaining for chemical industry enters critical phase	DP
Mar. 19	Bernstein Starts Merck KGaA Coverage at Market Perform	MT
Mar. 18	TrumpRx lists many medicines at prices higher than paid in UK	RE
Mar. 16	MERCK KGAA : Buy rating from JP Morgan	ZD